Login / Signup

ECPR for refractory OHCA - lessons from 3 randomized controlled trials. The trialists´view.

Johannes F H UbbenSamuel HeutsThijs S R DelnoijMartje M SuvereinAnina F van de KoolwijkIwan C C van der HorstJos G MaessenJason BartosPetra KavalkovaDaniel RobDemetris YannopolousJan BělohlávekRoberto LorussoMarcel C G van de Poll
Published in: European heart journal. Acute cardiovascular care (2023)
Extracorporeal cardiopulmonary resuscitation is a promising treatment for refractory out-of-hospital cardiac arrest. Three recent randomized trials (ARREST-trial, Prague OHCA study, and INCEPTION-trial) that addressed the clinical benefit of ECPR in out-of-hospital cardiac arrest, yielded seemingly diverging results. The evidence for extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest, derived from three recent RCT's, is not contradictory but rather complementary. Excellent results can be achieved with a very high level of dedication, provided that strict selection criteria are applied. However, pragmatic implementation of extracorporeal cardiopulmonary resuscitation does not necessarily lead to improved outcome of refractory out-of-hospital cardiac arrest. Centers that are performing extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest or aspire to do so, should critically evaluate whether they are able to meet the prerequisites that are needed to conduct an effective extracorporeal cardiopulmonary resuscitation program.
Keyphrases
  • cardiopulmonary resuscitation
  • cardiac arrest
  • study protocol
  • randomized controlled trial
  • clinical trial
  • quality improvement
  • phase ii
  • cell cycle
  • open label